by Madaline Spencer | Feb 29, 2024
Julia Alton, Executive Director at the Canadian Fabry Association, discusses the poster presented at WORLDSymposium 2024, “Exploring the experience of females living with Fabry disease in North America.” Fabry disease is a lysosomal storage disease...
by CheckRare Staff | Feb 26, 2024
Tyler Sandahl, PharmD, Clinical Pharmacist at the Mayo Clinic, discusses the use of tocilizumab in multiple myeloma patients. Multiple myeloma is a cancer that occurs due to abnormal, uncontrolled growth of plasma cells in the bone marrow. The most...
by CheckRare Staff | Feb 21, 2024
Davide Martino, MD, McMaster University Department of Medicine, discusses the BASIS clinical trial, a phase 3 study testing marstacimab in patients with hemophilia without inhibitors. Hemophilia is a bleeding disorder that slows the blood clotting...
by CheckRare Staff | Feb 17, 2024
Nicole Miller, PhD, Vice President of Molecular Diagnostics at Ultragenyx Pharmaceutics, explains the importance of improving newborn screening and the limitations of current processes. The Recommended Uniform Screening Panel (RUSP) is a list of...
by CheckRare Staff | Feb 16, 2024
« Prev1 / 1Next »Subtypes of CTCL: Mycosis Fungoides and Sézary Syndrome (Full Interview)CTCL: Mycosis Fungoides and Sézary Syndrome Overview (Chapter 1)Diagnosis of Mycosis Fungoides and Sézary Syndrome (Chapter 2)Importance of Accurate Staging When...
